A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
Phase 1
29
about 5.4 years
≤25
1 site in TN
What this study is about
This trial is testing dalbavancin, a medication, as a preventative measure against bacterial infections in children and adolescents with leukemia who are receiving chemotherapy. The goal is to see how effective this treatment is at preventing bloodstream infections and other complications.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Dalbavancin
- 2.Take Fluoroquinolone (either ciprofloxacin or levofloxacin at the discretion of the treating clinician)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
dalbavancin, antibiotic (Fluoroquinolone antibiotic; inhibits bacterial DNA gyrase)
injection, intravenous, oral (Oral Tablet)
Secondary: Dalbavancin peak plasma concentration (Cmax) - Median and range, Tolerability of dalbavancin
Oncology